Synchronous Colon Cancer and ALK Positive Lung Cancer

Abstract We present a case of synchronous ALK positive lung cancer and colon cancer. Patient presented to the hospital for routine health checkup and was incidentally detected with both the cancers. Initially it was thought to be colon cancer with lung metastasis. IHC was done on the lung biopsy specimen which was positive for TTF1 and ALK mutation and negative for SATB2. Colon specimen was also reported as mucinous adenocarcinoma histopathologically but IHC was negative for ALK mutation. Hence the diagnosis of synchronous double malignancy was made. Both the cancers were locally advanced without any distant metastasis. Curative resection is done for both the lesions along with targeted therapy for the lung cancer and adjuvant chemotherapy for the colon cancer

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-30
DOI
https://doi.org/10.5281/zenodo.15430305
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synchronous Colon Cancer and ALK Positive Lung Cancer

Zenodo (CERN European Organization for Nuclear Research)
Multiple and Secondary Primary Cancers
article

Synchronous Colon Cancer and ALK Positive Lung Cancer

article en

Abstract

Abstract We present a case of synchronous ALK positive lung cancer and colon cancer. Patient presented to the hospital for routine health checkup and was incidentally detected with both the cancers. Initially it was thought to be colon cancer with lung metastasis. IHC was done on the lung biopsy specimen which was positive for TTF1 and ALK mutation and negative for SATB2. Colon specimen was also reported as mucinous adenocarcinoma histopathologically but IHC was negative for ALK mutation. Hence the diagnosis of synchronous double malignancy was made. Both the cancers were locally advanced without any distant metastasis. Curative resection is done for both the lesions along with targeted therapy for the lung cancer and adjuvant chemotherapy for the colon cancer

Zenodo (CERN European Organization for Nuclear Research)
Innovative Research (United States) (US)
Good health and well-being
Openalex Percentile: Top 56%
Multiple and Secondary Primary Cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.